Pathophysiology of nephrogenic systemic fibrosis: A review of experimental data. - Wikidata - awgldk - TriplyDB

Pathophysiology of nephrogenic systemic fibrosis: A review of experimental data.

Pathophysiology of nephrogenic systemic fibrosis: A review of experimental data.

http://www.wikidata.org/entity/Q33778292

about

Scleroderma Mimickers Pediatric nephrogenic systemic fibrosis is rarely reported: a RADAR report.Risk of nephrogenic systemic fibrosis is low in patients with chronic liver disease exposed to gadolinium-based contrast agents.Technical considerations in MR angiography: an image-based guide.

P2860

Q33625658-DE8BEF8D-CEC2-438A-BF8D-642CA475458F Q37624891-6DE09302-5F11-431F-9067-40C1371EF7A6 Q38210490-16F8545F-A88B-4679-A951-06D971D2BB25 Q46269367-1DD657AE-496A-416F-8781-CC183B8917C0

P2860

Pathophysiology of nephrogenic systemic fibrosis: A review of experimental data.

http://www.wikidata.org/entity/Q33778292

description

2010 nî lūn-bûn

@nan

2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Pathophysiology of nephrogenic systemic fibrosis: A review of experimental data.

@ast

Pathophysiology of nephrogenic systemic fibrosis: A review of experimental data.

@en

type

label

Pathophysiology of nephrogenic systemic fibrosis: A review of experimental data.

@ast

Pathophysiology of nephrogenic systemic fibrosis: A review of experimental data.

@en

prefLabel

Pathophysiology of nephrogenic systemic fibrosis: A review of experimental data.

@ast

Pathophysiology of nephrogenic systemic fibrosis: A review of experimental data.

@en

P1433

Q33778292-6B38E624-CD6D-4BB3-B1E0-4563D4B0E839

P1476

Q33778292-4D19D294-AEF8-4021-A0B7-F338807A304B

P2093

Q33778292-29F6910D-E441-423F-91E7-270CFCB9C4FE

Q33778292-6ED096A3-7ACC-43D0-8824-1DB234E57E11

P2860

Q33778292-06D1DC44-B92C-4ED8-BE38-231990C9CDBE

Q33778292-0CBF79D1-4EF8-41C2-BD4E-D6CA500F10BA

Q33778292-3E86AB55-1F45-4A27-AB08-9DA1C6ADAC48

Q33778292-4E41C0F6-34FB-41A7-8D44-5D3E06F2B182

Q33778292-5B825962-E87B-4393-BD50-4DAAEEC5D451

Q33778292-63A6DAC1-5D00-4F47-8BA7-89AD0A4380B0

Q33778292-71C6C0CE-A3C6-4BB6-85CD-0DEE0529E5D8

Q33778292-9A2EE28A-078E-42A5-9B29-11AEBA6C2A1C

Q33778292-9B8B87A3-6F2E-4BED-A67A-5C5373CB7F34

Q33778292-9B908EB7-3F09-45F7-A123-0DE390DBB26F

P304

Q33778292-63143432-47B2-4160-94CA-45CC6E2E7BFB

P31

Q33778292-0f174dc5-32ab-4f5b-9e3b-47122d70d464

Q33778292-2D431B48-8AC0-4291-94FD-1830A9409E26

P356

Q33778292-73922ACC-B0DE-4B51-9830-A9CE168CCBB2

P433

Q33778292-DA22A440-21D9-4F37-A219-5ED74C0AC626

P478

Q33778292-B09C843F-0FCF-41E5-8A01-A7DEBA382802

P577

Q33778292-B9EC72A1-E89C-4C42-AB06-BF188A1E02AD

P5875

Q33778292-9E9A9088-14E2-4951-8F77-079B4F113F43

P698

Q33778292-DAC3DCD7-2722-443E-B338-237D6F2AF01B

P921

Q33778292-A46DC07A-5FA8-4B8A-A351-812AD9925B29

P932

Q33778292-3BB0D163-023B-4989-874D-6AFD0B26394C

P356

P1433

World journal of radiology

P1476

Pathophysiology of nephrogenic systemic fibrosis: A review of experimental data.

@en

P2093

John Haylor

http://www.w3.org/2001/XMLSchema#string

Sameh K Morcos

http://www.w3.org/2001/XMLSchema#string

P2860

Nephrogenic Systemic Fibrosis: Suspected Causative Role of Gadodiamide Used for Contrast-Enhanced Magnetic Resonance Imaging

Gadolinium - a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?

Stability of MRI paramagnetic contrast media: a proton relaxometric protocol for transmetallation assessment.

Comparative study of the physicochemical properties of six clinical low molecular weight gadolinium contrast agents.

Efficiency, thermodynamic and kinetic stability of marketed gadolinium chelates and their possible clinical consequences: a critical review.

Gadolinium deposition in nephrogenic fibrosing dermopathy.

Clinical and histological findings in nephrogenic systemic fibrosis.

The promotion of collagen polymerization by lanthanide and calcium ions.

Gadolinium-based contrast agents and their potential role in the pathogenesis of nephrogenic systemic fibrosis: the role of excess ligand.

Impact of renal impairment on long-term retention of gadolinium in the rodent skin following the administration of gadolinium-based contrast agents.

P304

427-433

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4329/WJR.V2.I11.427

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P577

2010-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49703294

http://www.w3.org/2001/XMLSchema#string

P698

21179310

http://www.w3.org/2001/XMLSchema#string

P921

pathophysiology

P932

3006481

http://www.w3.org/2001/XMLSchema#string